SCHEMBL17423641

SCHEMBL17423641

CC(C)Oc1cc(F)ccc1CC=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 1/20 0.38
ALDH1A1 P00352 2/20 0.35
CTSS P25774 1/20 0.35
CTSK P43235 1/20 0.35
KCNH2 Q12809 4/20 0.34
TMEM97 Q5BJF2 3/20 0.34
SIGMAR1 Q99720 3/20 0.34
CSNK2A1 P68400 2/20 0.34
HTR2A P28223 1/20 0.34
SLC6A4 P31645 1/20 0.34
MEN1 O00255 2/20 0.33
HPGD P15428 2/20 0.33
KMT2A Q03164 2/20 0.33
MAPT P10636 2/20 0.33
POLB P06746 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ACLY P53396 1/20 0.33
P2RX3 P56373 1/20 0.33
NTRK1 P04629 1/20 0.33
CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8418212 0.83 KCNH2 (0.38) ALDH1A1KCNH2TMEM97SIGMAR1CSNK2A1
SCHEMBL29531337 0.81 ALDH1A1 (0.44) FFAR4ALDH1A1HTR2AMEN1HPGD
SCHEMBL4434656 0.81 ALDH1A1 (0.44) FFAR4ALDH1A1HTR2AMEN1HPGD
SCHEMBL21598357 0.81 AR (0.38) FFAR4ALDH1A1KCNH2CSNK2A1HTR2A
SCHEMBL28573110 0.80 CSNK2A1 (0.38) KCNH2TMEM97SIGMAR1CSNK2A1HTR2A
SCHEMBL3361954 0.80 IRAK4 (0.43) FFAR4ALDH1A1KCNH2SLC6A4HPGD
SCHEMBL17423620 0.79 MAPK1 (0.40) ALDH1A1CTSSCTSKMEN1HPGD
SCHEMBL20818373 0.78 CSNK2A1 (0.40) KCNH2TMEM97SIGMAR1CSNK2A1HTR2A
SCHEMBL20818300 0.78 KCNH2 (0.37) KCNH2TMEM97SIGMAR1CSNK2A1HTR2A
SCHEMBL21456022 0.76 AGBL2 (0.46) FFAR4P2RX3IRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3166937-A1 ANTIPROLIFERATIVE COMPOUNDS AND METHODS OF USE THEREOF Celgene Corporation (US) 2017-05-17 EP disclosed
WO-2016007848-A1 ANTIPROLIFERATIVE COMPOUNDS AND METHODS OF USE THEREOF CELGENE CORPORATION (US) 2016-01-14 WO disclosed